.
ࡱ > z { | } ~ \ p apligina B a = = h< L, 8 X@ " 1 " A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C y r 1 " h A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C Y R 1 " A r i a l C y r 1 . T i m e s N e w R o m a n 1 " A r i a l C y r 1 " $ A r i a l C y r 1 A r i a l 1 " A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C Y R 1 " A r i a l C y r 1 . T i m e s N e w R o m a n 1 . T i m e s N e w R o m a n 1 " A r i a l C y r 1 A r i a l 1 A r i a l 1 " A r i a l C y r / # , # # 0 " @. " ; \ - # , # # 0 " @. " 9 # , # # 0 " @. " ; [ R e d ] \ - # , # # 0 " @. " ; # , # # 0 . 0 0 " @. " ; \ - # , # # 0 . 0 0 " @. " E # , # # 0 . 0 0 " @. " ; [ R e d ] \ - # , # # 0 . 0 0 " @. " k * 3 _ - * # , # # 0 " @. " _ - ; \ - * # , # # 0 " @. " _ - ; _ - * " - " " @. " _ - ; _ - @ _ - k ) 3 _ - * # , # # 0 _ @_ . _ - ; \ - * # , # # 0 _ @_ . _ - ; _ - * " - " _ @_ . _ - ; _ - @ _ - { , ; _ - * # , # # 0 . 0 0 " @. " _ - ; \ - * # , # # 0 . 0 0 " @. " _ - ; _ - * " - " ? ? " @. " _ - ; _ - @ _ - { + ; _ - * # , # # 0 . 0 0 _ @_ . _ - ; \ - * # , # # 0 . 0 0 _ @_ . _ - ; _ - * " - " ? ? _ @_ . _ - ; _ - @ _ - # , # # 0 . 0 0 " @. " % [$-F800]dddd\,\ mmmm\ dd\,\ yyyy ; [ $ - F C 1 9 ] d \ m m m m \ y y y y \ " 3. "
, * + ) " ( ( ( ( ( ( x@ @
@ @
(
( ( ( ( ( Z |@ @
( @ @ ( @ @ ( @ @ @ @ ( ` 6 8AB1 X 8AB2 _ 8AB3 !
=
" = " 5 iY}=Kҭ @= iY}=KҭD x xOTI ǿ
::i% f(" q:LQQ4 1у0M EZ=a?UTˣ1vU]B`# Cday{&ֳ韲{t\Xqs? rݨ/EvkNB'8?)_'țM C[~ҧ \ƶ5(?=GM0P"FD " VàuAիtUgԯpڠY}%`:J,*mڢ֚]uɸL5j.QڭN]jI_=xj/+=HQ8[]0Ut=ګEԓj4;
m%rk:]̻YE}d䮎SRiczHXjd7{K/D,'~Rb(Ǧ U|kqRgccd8ə"ijy2ܨp??ܑL3}-s?2PV`||wJMg_Kx[;V ^ѿcZŸn!6z3᱕o0MFC?r 0!EW1k]L"7 z;p "PDbHSB{{O
cB!PC|#O@z<
c~7z¾}zގ]5 "u Ρ VZ7^Zk:h&N 56䃬`?5 e.O&M;N~Szq A0qCŰ8q
7ac/ tJ:n[҉eʎ^w}/gcO;M3 A @ @ ) , &8?@>D;>:A0F8= B01 5 0 0 <3 !1 0 &8B@0= B01 !6 '01@5F0 B@020 D/ ? 1 , 5 3 !2 0 / '09 5BOI0O ;0AB>G:0 D@C:B 3 3 !2 0 ;07 4@0:>=0) '09 5BOI0O ;0AB>G:0 D@C:B 3 3 !2 0 O1;>:> '0AK ?5A>G=K5 1 G=K5 3 G=K5 5 @B5 B01 0 , 2 5 3 !5 0 (0;D59 B01 !2 0 (0;D5O ;8ABLO 5 0 3 :>@>1:0 (8?>2=8:0 ?;>4K D/ ? !2 0 ( (?@8F >4=>@07>2K9 2 4=>@07>2K9 5 4=>@07>2K9 1 0 4=>@07>2K9 2 0 <; e c t o n D i c k i n s o n -4=8B B01 2 0 @ 2 0 % 5 0 AD0B 0 , 1 3 2/ 2
!B02:0 !( R e n u 0AB2>@ M u l t i P l u s D; 2 4 0 @ M u l t i P l u s D; 3 5 5 @ M u l t i P l u s D; 6 0 2K9 =01>@ 0B5@80 548:0 %>;48=3 $ 3@8 45BA:89 B01 !4 0 3@8 B01 !4 0 45;LD0=- M784@5:A B01 !2 5 0 45;LD0=- M784@5:A B01 !3 0 * 7C;0= M:B- B 4/ ?@ @- @0 9 0 3 D; ( >@=528I0 1 0 0 3 :>@>1:0 8@0 :>@=528I0 5 0 3 :>@>1:0 :B>2538= 0<? 2 2538= B01 ?/ > !3 0 :B>2538= :@52538= B01 ?/ > !5 0 ;L45F8= A?@59 5 0 <:3 8 , 5 3 D; <8:A8= B01 6 0 <3 !1 0 ( 8=4 C?) <8=078= 0<? 2 , 5 % 2 <; !1 0 :>< <8B@8?B8;8= 0<? 1 % 2 4=K5 B5E=>;>388 8 <0@:5B8=3 :A8:;02 ?>@ 4/ 8= D; 1 , 2 3 !5 =0;3>A :@5; :0?A 1 0 0 - :B82 :0?A 3 0 0 <3 !4 0 @CB8; D; 0 , 2 5 % 5 <; @CB8; D; 0 , 5 % 5 @18=>20O :- B0 A A0E0@>2 ( 10;L70G=8: 4>;3>;5B8O B5=>;>; B01 5 0 <3 !5 0 ( 8=4 C?) * "$ 0<? 1 % 1 : 3>4=>AB8 2 3>40) % F848=- ?5?A8= B01 0 , 2 5 3 !5 0 ( 8=4 C?) F8:;>28@ 28@ B01 2 0 0 <3 !2 0 FF 3@0=C;OB 2 0 0 ;>B=>3> ?>1538 5 0 3 :>@>1:0' 0:B5@8>D03 AB0D8;>:>::>2K9 D; 2 0 35= $# $' 0:B5@8>D03 AB0D8;>:>::>2K9 D; 2 0 B5:A 0;L70< 8BB=5@0 D; 2 5 0 <; 0;L70< 8BB=5@0 D; 5 0 <; 0;L70A:>28O D; 6 0 % 2 5 0 ;8MB8;5=>2K5 ( ?0@0) China MEHECO Medical Instruments 5918 0;< D; 1 5 <; :0?;8 %8AC=8B 5=- 359 :@5;L D; 1 <;= 5?0=B5= :@5< 5 % 3 0 3 BC10 GP Grenzach Produktions 5@;8?@8; 5 B01 5 2K9 1 5 E3 0 0 0728B85 $ F 8=B M;0AB8G=K9 1 0 A< E 1 , 0 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9F 8=B M;0AB8G=K9 1 0 A< E 1 , 5 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9D 8=B M;0AB8G=K9 1 0 A< E 2 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9F 8=B M;0AB8G=K9 1 0 A< E 2 , 5 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9D 8=B M;0AB8G=K9 1 0 A< E 3 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9D 8=B M;0AB8G=K9 1 0 A< E 4 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9G 8=B M;0AB8G=K9 7 , 5 A< E 1 , 5 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9E 8=B M;0AB8G=K9 7 , 5 A< E 2 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9E 8=B M;0AB8G=K9 7 , 5 A< E 3 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9 8>28B0;L N 4@ !6 0 8>28B0;L 35;L 1 7 5 3 4;O 45B59 8A0:>48; 4@065 5 48; AC?? @5:B 1 0 <3 !1 0 8D84C7 !3 0 8:@>35= ( ;;5@35= $# ) 8:@>35= ( <?@5?0@0B) ><- 15=35 28A % >O@KH=8:0 =0AB>9:0 D; 2 5 2K9 75;5=K9 :0@0=40H 3 <35:A8= <8:ABC@0 D; 1 5 0 ? D; 1 0 0 @>1:0% CB>@D0=>;0 B0@B@0B 0<? 0 , 2 % 1 @D0=>;0 B0@B@0B 0<? 0 , 2 % 1 2>5 D; 1 0 0 2>5 D; 4 0 <; 078;8? B01 1 0 078;8? B01 2 0 078;8? B01 2 0 <3 !2 8 < 0:F8=0 BC15@:C;57=0O ( &) 0@840 2 <; !5 ( 0:F8=0 BC;O@5<89=0O 6820O 07 0;5@80=K =0AB>9:0 D; 5 0 <; 0;5@80=K M:AB@0:B B01 2 0 <3 !5 0 1 0;5@80=K M:AB@0:B B01 2 0 ; B01 0 , 0 6 3 !6 & 0B0 38385=8G5A:0O D0A>20==0O ?> 2 5 3& 0B0 38385=8G5A:0O D0A>20==0O ?> 1 0 0 3 0B=K5 48A:8 S o f t C a r e !1 0 0 5 0 0 3 Shenzhen top one indystry 0B=K5 48A:8 S o f t C a r e !4 0 5 0 0 1 0B=K5 48A:8 S o f t C a r e !8 0 5 0 0 2 # 0B=K5 ?0;>G:8 S o f t C a r e !1 0 0 4 0 0 1 Guangzhou yue xiu enterprise/ 0B=K5 ?0;>G:8 S o f t C a r 5 !5 0 :@C3;K9 ?5=0; 4 0 1 0 2 0B=K5 ?0;>G:8 S o f t C a r e !4 5 A >3@0< =8G8B5;5< 4 0 1 5 5=70 :0?;8 D; 2 0 @CB>= 35;L 2 % 4 0 3 5=>@CB>= :0?A 3 0 0 <3 !5 0 ! 5@0?0<8;0 3/ E 0<? 0 , 2 5 % 2 H?8@>= :0?A 1 0 0 H?8@>= :0?A 5 0 <3 !3 0 803@0 B01 1 0 0 <3 !4 . 803@0 B01 2 5 ; D;- :0? 1 0 <; F5B8= 0<? 0 , 5 % 2 F5B8= B01 0 , 0 0 5 3 !2 0 ( 8=4 C?) 8B! B01 !6 0 8B0<8= :0?A 3 3 0 0 5 0 <3 !2 0 8B0<8= :0?A 5 0 0 0 5 0 <3 !2 0 8B0<8= 1 2 0<? 2 0 0 <:3 1 <; !1 0 " 8B@C< :0;LF89+ 28B0<8= D 3 B01 !1 0 0 8B@C< 84A 6520B B01 !3 0 & 8B@C<5=A B01 !3 0 ( A 65=LH5=5<) 8B@C< B01 !3 0 8B@C= 2 A25G8 5 0 0 BKA !1 0 8H=52A:>3> ;8=8<5=B 1 0 0 3 $0@20F8O # 8H=52A:>3> ;8=81M=78 >;LB0@5= AC?? 1 0 0 ;LB0@5= AC?? 5 0 <3 !1 0 8@0<8AB8= D; 0 , 0 1 % 5 0 < B01 2 5 0 @20A: B01 1 0 ; ACA?. D; 1 0 0 H?@8F 0=B5=>; 0M@ 1 3 0 3 8<0DCF8= B01 1 0 0 =- ! 0<? 3 ;?0458= B01 @0AB2>@8;L25=F89 D; 2 5 <; !?07= B01 !2 0 "@>:A52078= 35;L 2 % 4 0 3 "@>:A52078= :0?A 3 0 0 AB0B D; 0 , 2 % 5 0 = D; 1 3 2/ 2 2/ Wernigerode Pharma -A?C<870= :0?A 4 0 @0B0 D; 2 0 % 3 0 3 0B@8O E;>@84 0<? 0 , 9 % 5 @84 D; 0 , 9 % 2 0 0 3;8F5@8= 0<? 0 , 1 % 5 :A>;8= B01 5 0 2>:08= D; 0 , 2 5 % 2 0 0 @@B5 4@065 !1 0 & 548:C;8F84=K9 H0;H51=0O ?0;>G:0) !3 Shang Hai Latex @575@20B82 /( ( 09D) !3 @575@20B82 /( !3
$;>@0 02:070 >;O@8A ' K189 68@ :0?A 0 , 3 3 !1 0 0 A @0AB>@>?H59 !0;8F8;>20O A=K ?>G:8 3 5 3 :>@>1:0 "5@0D;N ?>@ !1 0 @0AB2>@8@0- $0@B :0H;O !1 0 075;8= <548F8=A:89 3 0 3 BC10 I t a l f a r m a c o / $0@@ 1C?@>D5= B01 2 0 0 B8D5= B01 1 ?;0ABK@L 10:B5@8F84=K9 3 , 8 E3 , 8 59:>?;0ABK@L 10:B5@8F84=K9 4 E1 0 8:@>35= 8><54 5@;>:=O=:8 ;8ABLO 5 0 3 :>@>1:0 #A?>:>9 B01 !2 0 >7@>645=85 8 072 >=F5@= !B8@>; ;8F8= B01 1 0 0 < ;LD0?;0AB8: 8@0F5B0< 0<? 2 0 % 5 @ Milton 0B0 E8@C@38G5A:0O AB5@ 2 5 0 3 52>;L 2K9 75;5=K9 D; 1 % 1 0 2;5=85 $ @><:0@0 B01 2 5 0 <3 !3 0 8B@C@ B01 !6 0 >;LB0@5= M<C;L35;L 1 % 2 0 3 BC10 0AB0; B01 !3 0 @0=40:A8= B01 5 0 D5=0: 0<? 7 5 <3 3 2 0<? 3 0 <3 1 <; !1 0 ;0F84 ! B01 5 0 0 1 0528I0 ( @A:0O :0?CAB0) 5 0 3 :>@>1:0! OBK ?5@5G=>9 ;8ABLO 3 5 3 :>@>1:0 >@10:B8= B01 4 0 0 = B01 !2 1 ?/ > " - 2 !51>7>; ( :5B>:>=07>; 1 % ) H0B ?5@E>B8 1 0 0 @>1:0 $5=81CB B01 2 5 0 4=>@07>2K9 3 - E :><? 1 0 <; 5B@0;5:A B01 5 0 0 2:0 % - 8 Merz6 !?@8=F>2:0 % - 6 ( A 2 - =5G=, ; B01 !1 1 2 803@0 B01 5 0 <3 !1 . @5AB0@8C< B01 8 2>- F8=:>20O D0@20O <07L 1 % 1 0 3 3;07=0O 097 B01 5 0 <8F8=0 ;8=8<5=B 1 0 % 2 5 3 BC10 &8==0@878= B01 2 5 ;5=A:>5
8@8>= 3@8 2 0 3 2 ?0: ?> 1 0 3 0=>=D0@40:H= 8D5@>= 1 A25G8 1 5 0 BKA !1 0 $ <<C=0; D; 5 0 <; 5:BCA8= B01 !1 0 !:8=- 0? H0<?C=L 1 5 0 <8F5B8= B01 5 0 0 @ 2 0 3 5B8;C@0F8; AC?? @5:B 5 0 0 ; B01 1 0 <3 !2 0 ;09=D0@D;>:A0F8= B01 2 5 0 <3 !1 0 ( 8=4 C?) -=0? B01 2 , 5 <3 !2 0 Terapia $% 8< !5 @>35AB5@>= 0<? 2 , 5 % 1 <; !1 0 86D0@;8F09 B01 !4 K R K A / 5:B>@ Galena Pliva0 8=B M;0AB8G=K9 8 A< E 1 , 5 9- :;8?A>9" 8D84C9 D; 5 4>7 !1 0 -:>?>;8A ;N:>70 B01 0 , 5 3 !1 0 >@40D;5:A B01 1 0 <3 !1 0 0 <8:A8= B01 1 2 5 = B01 !2 0 5@=8A>= 3@0= 1 0 3 ND0;0: A8@>? D; 2 0 0 <8F5B8= BN1- :0? 0 , 2 5 % 1 0 :>84 @8= A?@59 =07 D; 0 , 1 % 1 0 <; Sandoz 70;5?B8= B01 0 , 1 3 !5 0 ( 8=4 C?) 78B CA :0?A 0 , 2 5 3 !6 2538= 0<? 2 3> >B45;0- 8A5;520 !25B;0=0 ;53>2=0 8 - 9 0 3 - 7 8 1 - 6 2 - 4 5 &5=K 2:;NG0NB !! :@845@< :@52538= B01 ?/ > !1 0
>48;;8O- D0@<& =B83@8??8=- 0:A8<C; A25G8 @5:B !1 0 A:>@CB8= B01 !5 0 B5=>;>; B01 5 0 ;L D; 4 0 0 3B59 D; 3 3 8D84C9 ?0:5B !1 0 >@=0O :8A;>B0 ?>@ 1 0 3% >@=>9 :- BK A?8@B>2>9 @- @ D; 3 % 1 0 2A:0O $$* 0;5@80=K :>@5=L 8 :>@=528I5 D/ ? 1 , 5 3 !2 0 % 5@0?0<8;0 3/ E B01 4 0 AB A25G8 5 0 3> ;8=8;LB0@5= 0<? 7 5 <3 3 ?5@84>; B01 5 <3 !5 0 ( 8=4 C?) 5 535= CAA:89 A :>:>A>:>;04=>9 3;07C@8 4 0 3 5?0@8= :A87>= 70 0<? 4 0 % 1 0 20O :>20==0O B8? - 1 ( 1 ;8B@) @5;:0 @578=>20O B8? @K1:0 83>:A8= 0<? 0 , 0 2 5 % 1 D5=0: AC?? @5:B 1 0 0 <3 !6 8; 0<? 1 % 1 ;L D; 4 0 0 =0 ?>@ 1 5 0 0 ?538B B01 2 5 0 D0<8=0 @- @ 0<? 0 , 5 % 5 G=K9 A>: =0BC@. D; 1 0 0 <; -:28=# C1=0O ?0AB0 0:0;NB A5=A8B82 5 0 = ;59:>F8B0@=K9 04- 0:B82 1 0 0 B01 !6 0 0;35;L 35;L 1 0 3 0;8O E;>@84 0<? 4 % 1 0 <; !1 0 0= 0M@ 3 0 @84 D; 0 , 9 % 4 0 0 ;8=) BN1- :0? 0 , 1 % 2 0 <; 0DB878= BN1- :0? 0 , 1 % 1 5 <; 518;5B B01 5 5>- =C7>; A25G8 !1 0 87>@0; H0<?C=L D; 2 0 <3 2 5 @5BB5 1 5 H?0= B01 !5 0 % 8AB0B8=>20O 3;8F5@8= ( =8B@>:>@) B01 5 0 0 - B5E=>;>38G5A:89 E>;48=3 "% 8D548?8= 4@065 1 0 5 ?@54?@8OB85 ?> ?@- 2C 10:B5@89= >2>:08= D; 0 , 5 % 2 0 0 ;8F8= B01 4 0 0 ;8F8= B01 4 0 0 @20A: B01 1 0 @20A: B01 5 - H?0 0<? 4 0 <3 2 - H?0 B01 4 0 - H?0 B01 4 0 - H?0 B01 4 0 70B>@ >- H?0 D>@B5 B01 8 0 - H?0;38= B01 !1 2 C@>D5= $>@B5 4 0 0 D5= ACA? D; 1 0 0 <3 5 <; 1 0 0 D5= B01 2 0 0 D5= B01 2 0 0 D5= B01 H8? 2 0 0 D5= #;LB@00? :0?A 2 0 0 @=8 1 0 0 3 :>@>1:0 :A8B>F8= 0<? 5 1 ;8=>20O 28B B01 !3 0 ; :0?A 0 , 0 2 3 !3 0 # @B>D5= ( >@B>D5@) <07L 2 % 3 0 3 BC10 @C=30; :0?A 1 0 0 <3 !1 4 B@828= :0?;8 0 , 0 5 % 1 0 <;( B@828= A?@59 0 , 1 % 1 0 <; M2:0;8?B- ;$ DB0;LD5@>= 3;07=K5 :0?;8 1 0 =B59=5@ 38?>B5@<8G5A:89 0=028@ 0<? 5 ; M:AB@0 B01 !1 2 ?/ > 0=78=>@@B5 4@065 !3 0 ! 0=:@50B8= B01 2 5 !6 0 ( 8=4 C?) 0=B5=>; A?@59 1 3 0 3 $0@; A?@59 5 8 3 0=B>:0;LF8= B01 0 , 2 5 3 !5 0 0=B>:@8= M:AB@0:B D; 5 0 <; 0?025@8=0 3/ E A25G8 0 , 0 2 3 !1 0 , 0@0F5B0; ACA?5=78O D; 2 , 4 % 1 0 0 =8AB " " - & "5E=>;>3 5@5:8AL 2>4>@>40 :0@0=40H 3 <; 5@A5= B01 !4 0 5@BCAA8= D; 1 0 0 :0@?8=0 3/ E D; 1 % 5 :0@?8=0 3/ E D; 1 % 5 10:B5@8>D03 ?>;820;5=B=K9 ( !5:AB0D03) D; 2 0 =0 =0AB>9:0 D; 1 0 0 =0 =0AB>9:0 D; 2 5 <; ( 8=4 C?) 0=0 =0AB>9:0 D; 5 0 <; ( 8=4 C?) I 8?5B:0 B@02157>?0A=0O 3;07=0O ( 2 DCB;O@5) ( 2 8=4 C?, ?0:5B, HB@8E- :>4) Marvel Life Sciences" 8@0F5B0< :0?A 4 0 0 G:8 1CG:8 =>A>2K5 S o f t C a r e !1 0 ;>M 5@0 6 0 0 3 0 ;0B>G:8 =>A>2K5 S o f t C a r e !1 0 5=B>;- 8= 6 0 0 4 , ;0B>G:8 =>A>2K5 S o f t C a r e !1 0 @>43C7=8:8 4;O 27@>A;KE S u p e r S e n i a i r m e d i u m 1 0 HB3 >43C7=8:8 4;O 27@>A;KE S u p e r S e n i a i r m e d i u m 3 0 HB >;845:A0 CH=K5 :0?;8 1 0 , 5 ;868=0:A :0?A !6 >;8D5?0= ?>@ 1 0 0 3, >:> 3 , 5 3 >AB8=>@ B01 0 , 7 5 EC459 G09 ?0:5BK !3 0 &M@5@0 >EC459 G09 ?0:5BK !3 0 0?5;LA8= >EC459 G09 ?0:5BK !3 0 28H=O >EC459 G09 ?0:5BK !3 0 75@ M u l t i P l u s D; 1 2 0 @5=L 7 5 3@ ?0:. $ 15=5 A8@>? D; 1 5 <3/ 5 <; 1 0 0 <; :A8:;02 ?>@ 4/ 8= D; 0 , 6 3 !5 $ =B83@8??8= H8? B01 !1 0 4;O 27@>AA;KE! =B83@8??8= H8? B01 !3 0 4;O 45B59 =B8?>E<5;8= B01 !6 ) =B8A5?B8G5A:89 @- @ D; 1 0 0 @18=>20O :- B0 4@065 !2 0 0 4 A:>@18=>20O :- B0 A A0E0@>D8B>D0@@ 2 , 5 3 $8B>@ 5 3 0:B5@8>D03 8=B5AB8 D; 1 0 0 D03 A0;L=5?;57=K9 D; 1 0 0 @B82=K9 :@5< 3 5 3 5@CH8 !2 ( 1 ?0@0) 3 @078;8OG 8=B M;0AB8G=K9 7 , 5 A< E 2 , 5 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>90 8=B M;0AB8G=K9 8 A< E 1 , 0 9- :;8?A>90 8=B M;0AB8G=K9 8 A< E 2 , 0 9- :;8?A>9 >O@KH=8:0 ?;>4K 1 0 0 3 :>@>1:0 >O@KH=8:0 ?;>4K 5 0 3 :>@>1:0 @><35:A8= B01 4 <3 !5 0 078;8? B01 1 0 ;+ 3;N:>70 B01 !1 0 0;>A5@48= D; 2 5 <; ( 8=4 C?) 0B0 E8@C@38G5A:0O AB5@ 1 0 0 3 5@:A B01 1 0 0 H?8@>= B01 2 5 <3 !2 0 8B0<8= :0?A 1 0 0 <3 !1 0
$5@59= 8B@C< LNB8 -;8B B01 !3 0 8B@C@B5 B01 !3 0 8B@C@B5 B01 !6 0 ! 8B@C< :0;LF89+ 28B0<8= D 3 B01 !3 0 8B@C< 84A 6520B B01 !6 0 8B@C<03 B01 !6 0 8B@C< @5=0B0; B01 !1 0 0 0;AB5=0 :0?;8 D;- :0? 2 0 <; 535=:0 :>:>A 5 0 3! 84@>:>@B87>= ?5@8B B01 1 , 5 3 !8 ;815=:;0<84 B01 5 <3 !5 0 CBB0;0:A :0?;8 D; 1 5 D0<8=0 0<? 4 % 5 D0@28B 4@065 !4 0 1C:;8= B01 4 0 0 <5B0F8=- :@8 ; @>2>5 D; 3 0 =0; D>@B5 4@065 1 0 0 <3 !2 0 ;0@8B8= B01 1 0 0:A8; B01 1 2 , 5 ! >;4@5:A E>B@5< ?0: !5 0 A@>48=0 >@20;>; B01 !2 0 $0@@>1:0 C@0=B8; B01 2 5 C@0=B8; 4@065 2 5 <8F5B8= D; 3 % 2 5 2>9 @0AB2>@ CNMAF$ 59:>?;0ABK@L :0BCH:0 4 E5 0 0 ( 8=4 C?) $ 59:>?;0ABK@L :0BCH:0 5 E2 5 0 ( 8=4 C?) , 59:>?;0ABK@L ?5@F>2K9 6 E1 0 ?5@D>@8@>20==K90 59:>?;0ABK@L AB5@8;L=K9 1 0 E1 0 A 2?8B. ?>4CH5G:>90 59:>?;0ABK@L AB5@8;L=K9 1 5 E1 0 A 2?8B. ?>4CH5G:>90 59:>?;0ABK@L AB5@8;L=K9 2 0 E1 0 A 2?8B. ?>4CH5G:>90 59:>?;0ABK@L AB5@8;L=K9 2 5 E1 0 A 2?8B. ?>4CH5G:>9. 59:>?;0ABK@L AB5@8;L=K9 6 E8 A 2?8B. ?>4CH5G:>9 00;>:A ACA? D; 2 5 0 A5?B8= A5?B8= @0B>@8A 0DB878= BN1- :0? 0 , 0 5 % 1 0 =3 D>@B5 B01 6 , 5 2830= B01 4 0 0 2>- ?0AA8B D; 1 0 0 <;. :A0<? =0B@8O D; 0 , 5 3 2/ 2 2/ < :A0<? =0B@8O D; 0 , 5 3 2/ D5= B01 0 , 0 2 5 3 !3 0 " D;>:A0F8= D; 2 <3/ <; 1 0 0 < D; 1 0 :>:F8=C< 3@0= 5 70 !6 C0@>= 01>@0B>@8O 0;8= :0?A 2 0 0 B5:A 5@A5= D>@B5 :0?A !2 0 $ 8>10:B5@8>D03 :><?;5:A=K9 D; 1 0 0 ;LD5= 4@065 2 5 <3 !2 0 " 8@0F5B0< :0?A 4 0 0 :A8:0B82>>6>3>2K9 35;L BC10 2 0 3 AB5@8;L=K9 0=8B848= B01 1 5 0 <3 !6 0 520;38= ( 10@0;38=) 0<? 5 <; !5 5;F5@ ACA? D; 1 8 0 <; 5==8 ; B01 !2 4 6520B 5==8 @A5?B B01 !1 2 ;8= AB@8?K& 8=70 >@A5?B B01 !1 2 <54- ;8= AB@8?K* 8=70 >@A5?B B01 !1 2 G5@. A@>48=0 AB@8?K ><0H:8 F25B:8 D/ ? 1 , 5 3 !2 0 !5A 1 % D; 3 <; !5==K ;8ABLO D/ ? 1 , 5 3 !2 0 !80;8A B01 2 0 Eli Lilly !8@40;C4 B01 2 <3 !3 0 !8@40;C4 B01 4 <3 !3 0 !:8?840@=0O ;:>A5@8; 0<? 2 ;:>A5@8; 35;L 65;5 2 0 3 Solco Basel AG. !B0:0=G8: 4/ ?@85<0 ;5:0@AB25==KE A@54AB2 3 0 <; !B@5?A8;A ;NA A?@59 D; 2 0 <; !B@5?A8;A ;NA B01 !1 6 & !C:@078B ( 70<5=8B5;L A0E0@0) B01 !1 2 0 0 Biscol% !C:@078B ( 70<5=8B5;L A0E0@0) B01 !3 0 0 !C?@0AB8= B01 2 5 <3 !2 0 "0:A8D5= B01 1 0 <3 !3 0 ( "8<0;8= D; 1 0 <3 2 @8B5;5< "8<0;8= D; 1 0 <3 !1 0 " "KAOG5;8AB=8:0 B@020 D/ ? 1 , 5 3 !2 0 #=4528B 4@065 !5 0 % #?A028B 8B0<8= ! B01 652 5 0 0 <3 !3 0 $0;8<8=B 4@065 2 5 <3 !2 0 $5@@C< 5: 0<? 1 0 0 <3 2 = G09 &5;51=0O ?>;O=0 !3 5 0 3 :>@>1:0 ;O ?>EC< 45=8O $;5:A8= A>;NB01 B01 1 2 5 =07>; ( D;C7>;) :0?A 0 , 1 5 3 !1 $;N:>AB0B :0?A 1 5 0 45@< :@545@< 45@< 4=>@07>2K9 3 - E :><? 3 4=>@07>2K9 3 - E :><? 5 <; 0BEM< $0@? D; 1 5 0 <; -@8CA B01 5 <3 !7 Schering( -DD5@0;30= # ! A 28B ! B01 H8? !1 0 BC10 -DD5@0;30= # ! A25G8 3 0 0 <3 !1 0 -=0;0?@8; B01 1 0 <3 !2 0 ( 8=4 C?) -=0;0?@8; B01 2 0 <3 !2 0 ( 8=4 C?) -=0;0?@8; B01 5 <3 !2 0 ( 8=4 C?) -=0;0?@8;0 <0;50B B01 1 0 <3 !2 0 -=0< B01 1 0 <3 !2 0 -@8=8B B01 0 , 0 1 3 !5 0 ( 8=4 C?) -A:C;NA <07L 3 0 3 BC10 -B0<78;0B B01 2 5 0 G=>9 E@0=8B5;L) !3 + @8AK?:0 -::>;M=4 3 0 3 45BA:0O D;0:>=- A?@59 @8AK?:0 -::>;M=4 4 0 3 45BA:0O 5;;0 @>:;04:8 5;;0 =>@:;04:8 5;;0 ;0AA8: A I R !1 0 + @>:;04:8 5;;0 ;0AA8: >20 :;04:8 5;;0 ;0AA8: >20 !1 0 I R , @>:;04:8 5;;0 ;0AA8: >20 :>@B A I R !1 0 @>:;04:8 5;;0 >20 !1 0 a i r $ @>:;04:8 5;;0 >20 :>@B !1 0 A I R $ @>:;04:8 5;;0 ?0=B8 A>DB !2 0 5654= @>AB0B8;5= A25G8 3 0 B82>>6>3>2K9 35;L ?0: 5 3 AB5@8;L=K9 CABK@=8:0 B@020 5 0 3 :>@>1:0 CABK@=8:0 B@020 D/ ? 1 , 5 3 !2 0 81>:A8= B01 2 0 0 ;4 B01 !1 0 8=>AB>? D; 0 , 0 5 % 1 0 AB>? D; 0 , 1 % 1 0 <; 8D0O@KH=8:>;O@8A 5;8B0 >BB0 :0?;8 D; 5 0 <; @C6:0 -A:A8= B01 5 0 35= ( ) 5:0@8A B01 1 5 0 2:0 @578=>20O - 3 C<?0= :0?;8 D; 2 0 <; $570@ 2 0 0 <3 !1 0 5=B5@ B01 5 0 0 <3 !1 0 0 K R K A / :@8E8= C<?0= :0?;8 D; 5 0 =B@0:BC15:A 35;L 2 0 3 !1 BC10) 0=>70682;ONI89 35;L BC10 2 0 3 AB5@8;L=K90 8=B M;0AB8G=K9 8 A< E 4 , 0 9- :;8?A>9 "@> !! B01 1 0 0 :>< :@5DLO ?G5;8=K9 O4 :@5</ B5;0 7 5 20O :>20==0O B8? - 2 ( 1 , 5 ;8B@0) ! -B0; B01 0 , 4 3 !1 0 0 ( 8=4 C?) " !>DLO ?G5;8=K9 O4 :@5</ B5;0 1 2 5 <; =0;L38= AC?? 1 0 0 ;4@5:A E>B@5< ?0: !1 0 <54- ;8= 5:A8:>= A25G8 !1 0 % &5D5:>= AC?? @5:B 5 0 <3 !1 0 45BA:85' -A?C<870= M<C;LA8O D; 4 0 <3 5 <; 1 0 0 <;% 8D84C@B5 ACE>9 ?0:5B !1 0 =4><5B0F8= A25G8 1 0 0 <5B0F8= A25G8 5 0 <3 !1 0 $0@@>1:0 %>=4@>:A84 20O :>20==0O B8? - 3 ( 2 ;8B@0) ;8F5@8= A25G8 2 , 1 1 3 !1 0 35:A0; A8@>? D; 1 0 0 F84 ;8=8@ @C4=>9 !4 5 0 3 :>@>1:0( >4>@>6=8:0 1>;LH>3> ;8ABLO 5 0 3 :>@>1:0% 1;5?8E>2>5 AC?? @5:B 0 , 5 3 !1 0 =5AB57>; A25G8 !1 0 8F5@3>;8= 0<? 4 <3 !5 + @- ;L !5 -=0< B01 5 D5@>= B01 1 5 0 <3 !1 0 0;L70< 8:C;O 7 5 <; 0;L70< 8:C;O 7 5 @> ;NA :@5< 2 5 3 0=B8A5?B8G5A:89 %8<0=8 578@B5 B01 1 4 0 2>9 :- BK @0AB2>@ 2 % 4 0 4>@>40 D; 3 % 4 0 :08= 3/ E 0<? 1 0 % 2 =0B :0?A 2 5 0 <3 !4 0 Grindex :A :0?A 2 5 0 =0B 0<? 1 0 % 5 <; !1 0 35:A0; B01 3 0 :A8D8;;8= B01 0 , 1 3 !6 0 * CB>@D0=>;0 B0@B@0B H?@8F- BN1 0 , 2 % 1 E>; B01 2 1 0 ?;0ABK@L 10:B5@8F84=K9 2 , 3 E7 , 2 @575@20B82 F r e n c h L o v e !3 :A8F8;;8= B01 0 , 2 5 3 !2 0 !B@C:BC< :0?A 5 0 0 = B01 2 5 = D; 2 3 !C<0<54 B01 5 0 0 <3 !3 . - !C?5@ C:8 :@5< A 10;L70AB0:>2A:>3> 7 5 3 0@=8 01>@0B>@8O A?5@0 !C?@048= B01 @0AB2 !1 0 Novartis Consumer/Famar 8><54 820! "0:A8D5= B01 1 0 <3 !3 0 ( 8=4 C?) "0=0:0= B01 4 0 <3 !3 0 "0=BC70 D; 1 4 0 <; !5 Angelini "0@8284 B01 2 0 0 "5;D0AB B01 1 8 0 "5=>@8: B01 1 0 0 ?M: B01 @5B 3 0 0 <3 !4 0 ( 8=4 C?) $ -7 "5@<5B@ 2>< DCB;O@5 Zhoushan4 "5@<5B@ <548F8=A:89 A 70I8B=K:@KB85< 2 DCB;O@59 "5@<5B@ 2>3@5AA82=K5 18>- ;>388 "5AB =0 15@5ABL K N O W N O W & "5AB>AB5@>=0 ?@>?8>=0B 0<< ? 5 % 1 <; !1 0 1 "5B@0F8:;8= + =8AB0B8= B01 1 0 0 0 0 0 !1 0 ( 8=4 C?) "5BC@0< B01 1 5 0 <3 !3 0 ( 8=4 C?) "5BC@0< B01 1 5 0 A?@59 0 , 0 5 % 1 0 A?@59 0 , 1 % 1 0 <; "878= D; 0 , 1 % 1 0 <; "835= A?@59 D; 0 , 0 2 5 % 1 0 ;- :@8 B01 0 , 5 3 !4 ?/ > "8@5>:><1 B01 !4 0 "4K 5 0 3 :>@>1:0E ">=><5B@ <548F8=A:89 2 @?CA5 - :- B A> A:>1>92 ">=><5B@ <548F8=A:89 - "3 - 0 1 - ! :- B !1 1 "@5=B0; 0<? 5 <; !5 "@5=B0; B01 1 0 0 <3 !6 0 . "@5=B0; B01 4 0 0 "@830=- 0<? 2 @ 1 0 <3 !1 0 D; !0= $0@; B01 !2 1 "@8A>;L D; 4 0 0 <; "@8DB078= 0 , 2 % 0<? 1 !! B01 5 0 @>1:0 #=8B8>; 0<? 5 % 5 <; !1 0 #?A0@8= # ! H8? B01 5 0 0 <3 !1 6
Berlimed S.A. $0ABC< 35;L 2 , 5 % 3 0 3 $0ABC< 35;L 2 , 5 % 5 0 3 $5=075?0< B01 1 <3 !2 0 $5=81CB B01 2 5 0 ; ?>@ 1 0 ?;5:A 4@065 !1 0 0 Biogal $5AB0; 4@065 !1 0 0 $5AB0; 4@065 !2 0 Turk Hoechst $8;LB@C<- !" B01 !5 0 ( 8=4 C?) $8=;5?A8= @5B0@4 B01 2 0 0 A25G8 CH=K5 !2 45BA:85 $8B>A25G8 CH=K5 !4 Astellas Pharma Europe B.V. $;5:A8= A>;NB01 B01 5 0 0 =07>; :0?A 0 , 0 5 3 !7 8 - 4>@>2L5 >AA89A:89 :0@48>;>38G5A:89 % 8>9 E8<88 828G0 $B>@>:>@B <07L 1 5 3. $C@038= B01 5 0 =8= B01 5 0 @35:A848= 183;N:>=0B D; 0 , 0 5 % 1 0 0 <; ( A?@59) =B8@35:A848= 183;N:>=0B D; 0 , 0 5 % 7 0 D0@@>?8@0<8= 0<? 2 % 1 A>;L D; 4 0 0 : C@A:0O 18>D01@8:0 %>;5=78 %>;>A0A D; 1 4 0 3+ %>=4@>8B8= 0<? 1 0 0 <3/ <; 1 =4@>;>=) %>=4@>8B8= :0?A 0 , 2 5 3 !5 0 %>=4@>;>= 0<? 0 , 1 <; !1 0 &5=B@C;878= 0<? 1 <; !1 0 &5B@8= ( 78@B5:) B01 1 0 ;8= D; 1 3 2/ 2 2/ B0:A8A8=) &5D>B0:A8< D; 1 3 2/ B0:A8< N 0 D; 1 3 2/ < 2/ 2 &5DB07848= D; 1 3 2/ 2 2/ D;0:>=) Shijiazhuang Co Ltd" 40@>= ( :>@40@>=) B01 0 , 2 3 !3 0 =0;L38= 0<? 5 0 % 2 @18=>20O :- B0 ?>@ 2 , 5 3# ;L D; 0 , 5 3 >D8F8; ?;NA B01 !1 0
" "@594 8F8=>= B01 2 5 0 ?;0ABK@L 10:B5@8F84=K9 6 E1 0 $ 59:>?;0ABK@L :0BCH:0 1 E3 0 0 ( 8=4 C?) $ 59:>?;0ABK@L :0BCH:0 2 E2 5 0 ( 8=4 C?) $ 59:>?;0ABK@L :0BCH:0 3 E5 0 0 ( 8=4 C?) $ 59:>?;0ABK@L :0BCH:0 5 E5 0 0 ( 8=4 C?) $ 59:>?;0ABK@L 7>;L=K9 ! 6 E1 0 # 59:>?;0ABK@L ?5@F>2K9 6 E1 0 42>9=>9 0DB878= BN1- :0? 0 , 1 % 1 0 <; <@ D; 1 0 % 4 0 <; A8= 0 , 5 !1 0 F5A>;L D; 2 0 0 <; 5;;0AB578= B01 !1 0 * 5AA3> F25B:8 5 0 3 :>@>1:00 8=B M;0AB8G=K9 8 A< E 2 , 5 9- :;8?A>91 8=B M;0AB8G=K9 8 A< E 5 , 0 :>9 @0ABO68AB8 8D84C9 ?0:5B !3 0 % 8D84C@B5 ACE>9 ?0:5B !3 0
>AB>2A:0O $$1 @8;;80=B>2K9 75;5=K9 D; 1 % 1 0 20O :@KH:0 CB048>= B01 0 , 1 5 3 !1 0 0;84>; B01 0 , 0 6 3 !1 0 !0;L=8:>20 . . & 0B0 38385=8G5A:0O D0A>20==0O ?> 5 0 3 EB0<0@% 5@0?0<8;0 3/ E B01 8 0 <3 !5 0 ( 8=4 C?) + 8B0<8= 2 0<? 1 D;028=) ' 8H=52A:>3> ;8=8?5@84>; 0<? 0 , 5 % 1 <; !1 0 535= !- 8B0 5 0 3
5=5AA ;8F5@8= D; 2 5 B8:8 0;0@38= 0<? 1 <3 !1 0 8D;N:0= :0?A 5 0 :A8F8:;8=0 3/ E :0?A 1 0 0 @0 1 0 0 3 :>@>1:0 5:@0AMB $ 5;GL <548F8=A:0O D; 2 5 0 <; ( 8=4 C?)
!0=- <54 =30;8?B 0M@ D; 3 0 <; <5B0F8= <07L 1 0 % 4 0 3 0@48:5B B01 @5B0@4 2 0 <3 !2 0 Schwarz Pharma 20<0B5; B01 4 0 ;0@8B8= B01 1 0 B@8; B01 203 1 0 0 ;<5 :0?;8 D; 1 5 ?0@:- &5=B@ " >D58=- 5=7>0B N a 0<? 2 0 % 1 <; !1 0 @C6:0 -A;20= A8@>? D; 1 5 <3 5 <; 1 0 0 @5=L 5 0 34 59:>?;0ABK@L 10:B5@8F. =01>@ 5A5;K5 4@0:>=G8:8 !1 2 8=8= <07L 3 0 3 BC10 54=K9 2A04=8: :0?;8 D; 2 5 <; AVEFLOR C@02L8=K9 A?8@B D; 5 0 =G8: 8H=O 9>3C@B 3 0 3# NA;8 10B>=G8: ;C1=8:0 9>3C@B 3 0 3( OBK ?5@5G=>9 =0AB>9:0 D; 2 5 3;8F5@8= :0?A 1 % 0 , 5 <3 !2 0 $0@<02>:08= 0<? 0 , 5 % 1 0 2>:08= 0<? 2 % 2 ;8?@5; B01 2 D5= ( >@B>D5@) 0<? 2 , 5 % 3 <; !1 0 2/ =8A- @> ( 8=4 C?) 70B8>?@8= 0 , 0 5 3 !5 0 <8=07< 8=- . !. 4@065 0 , 0 2 5 3 !1 0 <8=078=- . !. 4@065 0 , 1 3 !1 0 :A8:;02 B01 ?/ > 3 7 5 70 $ 8@8>= $# =0;L38= AC?? 2 5 0 <3 !1 0 4/ 45B59! =0?@8;8= B01 4 0 ; B01 5 0 D>>= B01; !4 0 8 A:>@18=>20O :- B0 A A0E0@>< B01 !1 0 :@CB:0 ( 8B0<8=:0 !) A?0@:0< B01 !5 0 ( 8=4 C?) + 0;L70;>B0O 725740 :0@0=40H 4/ 8=3 1 , 3 3 5;;025@8= B01 !1 0 5A0;>; B01 !6 5B0A5@: B01 1 6 40 4;O 8=J5:F89 0<? 5 <; !1 0 535= ??5B8B=K9 5 0 3 535= N18<K9 -:AB@0 5 0 3@ 535= 54>2K9 5 0 3 535= CAA:89 45BA:89 4 0 3 535= CAA:89 2K9 4 0 3, 535= CAA:89 >2K9 A ;5A=K@5E>< 4 0 34 535= CAA:89 A 87N:>;04=>9 3;07C@8 4 0 3( 535= CAA:89 A :54@>2K@5E>< 4 0 3 5457- D; 4 0 0 <; 5?0@8= D; 5 0 0 0 5 <; !5 5?B@0; B01 4 0 0 :>@B87>= 70 - D; 1 0 % 2 0 0 70 - D; 1 0 % 4 0 0 70 - D; 5 % 2 0 0 20O B8? A>;=KH:> @8??D5@>= 1 0 0 0 0 / <; 1 0 <; !1 80:0@1 B01 2 5 0 ; 0<? 1 % 1 ; 0<? 1 % 5 @ 0 , 2 5 D5=0: 35;L 1 % 3 0 3 8:;>D5=0: B01 5 0 >7D0@:A848= 0<? 0 , 5 % 1 0 :A848= 0<? 1 % 5 A?0= 0<? 1 ;L D; 2 0 0 <; 8B8;8= 0<? 2 % 5 :A>@C18F8=0 3/ E D; 1 0 :B>@ ?0AB8;:8 !2 0 0=0=0A @>?5@84>; 0 , 2 5 % 0<? 5 ? D; 5 0 0 ;L D; 4 5 0 <; 5;5=8=0 :0?;8 D; 2 5 28@0:A :@5< 5 % 2 3 C1=0O ?0AB0 0:0;NB 0:B82 5 0 <; C1=0O ?0AB0 0:0;NB C09B 5 0 =NE>2# =40?0<5B0F8= A25G8 5 0 7 D; 2 0 4- 0:B82 1 0 0 B01 !3 0 >4- 0:B82 B01 !4 0 >4- 0:B82 B01 !8 0 028=B>= 0<? 0 , 5 % 2 = B01 5 3>B:>2) F25B:8 3 5 3 :>@>1:0( 0;5=4C;0 ( =>3>B:>2) F25B:8 5 0 3 :>@>1:0( 0;5=4C;K ?0B8G5A:0O 3 0 3 BC10$ 0;5=4C;K =0AB>9:0 D; 4 0 @>B0B B01 0 , 5 3 !1 0 0;8O ?5@; ACA?5=78O D; 1 0 0 =0B 0<? 1 0 % 5 <; !1 0 0=484 :@5A ( A0;) 1 0 B5= B01 2 5 B5= B01 2 5 B5= B01 2 5 ?@8; B01 2 5 <3 !2 0 0@A8; 4@065 3 5 @ 5 0 3@ ;0D>@0= D; 1 3 ;525@ ;C3>2>9 D/ ? 1 , 5 3 !2 0 ;8>= B01 203 1 0 0 =48;8= D; 0 , 5 % 3 , 5 =B@0F5?B8=- " A25G8 !1 0 * >=F5=B@0B E2>9=K9 0 , 8 :3 66525;L=8: :>@ >@480<8= D; 1 5 ;18:8 A @K;LF0@>1:0 07>;20= B01 3 0 10:B5@8= ACE>9 D; 5 4>7 !1 0 8:@>35= ( 8>D8;LB@C<5B8; ?;0ABK@L S t r i p 3 , 8 E 3 , 8 59:>?;0ABK@L S t r i p 4 , 0 E 1 0 , 0 ) 59:>?;0ABK@L 10:B5@8F. =01>@ >@B !1 0 # 59:>?;0ABK@L 10:B5@8F84=K9 2 , 5 E7 , 2 5 59:>?;0ABK@L 10:B5@8F84=K9 2 , 5 E7 , 2 ' / ! $ 59:>?;0ABK@L :0BCH:0 2 E3 0 0 ( 8=4 C?) $ 59:>?;0ABK@L :0BCH:0 4 E2 5 0 ( 8=4 C?) 87>10:B B01 4/ @0AA. !3 0 8=B0@ B01 2 5 0 B>= 1 0 0 0 35;L 5 0 3 Menarini A. 0:A830= 0<? 5 ;C10O ;03C=0" @575@20B82 L U X E !3 0@B>2A:89 :>B* @575@20B82 /( ( (0?:0 =52848AB0:>@ ( @>AB0B8;5=) 0<? 5 <3 !1 0 2/ < <?@5?0@0B " C7K@L 4/ ;L40 !3 0C=0B8= B01 0 , 0 0 2 3 !1 0 ?/ > 5<5=A :0?;8 D; 5 0 <; 5==8 B>:0= D; 5 0 @8= D; 0 , 0 5 % 1 0 @ @C4=>9 !1 7 5 3 :>@>1:0 $0@>A- 2 1 !1>@ @C4=>9 !4 1 0 0 3 :>@>1:0 !5==K ;8ABLO 3 5 3 :>@>1:0! !5?B>;5B5 ?0AB8;:8 !3 0 1/ A0E0@0 !5@=0O ?@>AB0O ; 0<? 2 % 1 <; !1 0 2 ? 0;B59=K9 D; 1 2 5 30 !:0@8D8:0B>@ >4=>@07. AB5@8;L=K9 ( 1>:>2>5 :>?L5) !:8?840@=0O <07L 2 5 3 !D@045:A D; 5 ?0=38= 0M@ 3 0 <;! !B@5?A8;A B01 !2 4 ;- M2:0;8 ?>4:;04=>5 @578= !2 !C;LD0F8; N a BN1- :0? 2 0 % 1 <; !2 !C;LD0F8; N a D; 2 0 % 1 0 <; !C?@8=E> A8@>? D; 1 0 0 = 0<? 4 % 1 = D; 4 % 1 0 <; "5@0D;5:A :0?A !6 0 & "5AB =0 15@5ABL 2 , 5 << C l e a r t e s t Avolos Resources "5AB =0 15@5ABL B o n a d e a IND Diagnostic Inc "5AB =0 15@5ABL L a d y t e s t # "5AB =0 15@5ABL C4LB5 C25@5=K "@8A>;L D; 2 0 0 3@0D8= 0<? 6 0 % 2 0 <; !1 0 $5=075?0< 0<? 0 , 1 % 1 <; !1 0 $5=075?0< B01 0 , 5 <3 !5 0 $5=075?0< B01 1 3535= ?0AB8;:8 5 0 3 !1 6520B $8B>A25G8 CH=K5 !4 45BA:85 $C:>@F8=0 @0AB2>@ D; 1 0 <; $C@0F8;8= D; 1 0 @35:A848= 183;N:>=0B D; 0 , 0 5 % 1 0 0 @35:A848= 183;N:>=0B D; 0 , 0 5 % 1 0 0 %;>A>;L D; 2 0 0 =4@>8B8= <07L 5 % 3 0 3 &5@C:0; B01 1 0 = AC?? @5:B !1 0 &8B>28@- 3 :0?A !1 2 &8B><54 &8D@0= B01 2 5 0 2K9 M i c r o F i n e + 1 <; U - 4 0 -:78D8= ( ;0<878;) :@5< 1 % 1 0 3 ;8D5= -=0;0?@8; B01 1 0 B5:A -=0;0?@8; B01 2 0 <3 !2 0 -=0;0?@8; B01 5 ; <07L 3 0 3 BC10 -AA5=F80;5 0<? 5 <; !5 " -DD5@0;30= # ! B01 H8? 5 0 0 :A A>;NB01 B01 !1 0 C;LB8;=KH:> 2 0 0 2 # #3>;L 0:B828@>20==K9 B01 0 , 2 5 3 !1 0 8107>; B01 2 0 2538= 0<? 5 <; !5 <8:0F8=0 AC;LD0B D; 0 , 5 3 Sagmel Bouchara Recordati
!0@0=A:89 7- 4 $;CF8=0@ <07L 0 , 0 2 5 % 1 5 3. ;<035;L D; 1 7 0 = # 5=B0<8F8=0 AC;LD0B 0<? 4 % 2 @0 5 0 3 :>@>1:0 CH8FK B@020 3 5 3 :>@>1:0 ;8@20;>; D; 2 5 ?5@0<84 B01 2 ?@>B5= 1 0 0 B01 !4 0 !0=>@8=- =0;5@38= :0?;8 D; 1 0 @ #A?>:>8B5;L=K9 !3 D/ ? 2 3 !2 0 !5;@>1:0 =8:0 4 !:0@8D8:0B>@ >4=>@07. AB5@8;L=K9 ( F5=B@0;L=>5 :>?L5) # !:>@0O
5004.14 ()
mobil gargoyle
2111
thuraya sg 2510
ielts
.
outlook
shimadzu
8800 gold
knauf
-
754
cata
kiev apartments service
hi-fi
478
sky link
-
-934 .-
ipsec
-
restart
stiga
-4361
wow
metrobond
protherm
fargo
dvd-box
5440.11 ()
dimplex model lee rc
snr
-
dect desktop
icq
mobil gargoyle
funke
metabo
.